Commission Implementing Regulation (EU) 2024/324 [Commission Implementing Regulation (EU) 2024/324 of 19 January 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, bromuconazole, buprofezin, cyflufenamid, fluazinam, fluopyram, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metsulfuron-methyl, phosphane and pyraclostrobin (OJ L, 2024/324, 22.1.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/324/oj).] extended the approval period of the active substance pyraclostrobin until 15 September 2025, and the approval period of the active substance buprofezin until 15 December 2025.
Recital 24, Regulation (EU) 2025/1489
In forcesince 24 Jul 2025